Menu
19/10/2023
Almac To Create 550 New Jobs In Major Craigavon Expansion
The Almac Group has announced that it will create 550 new jobs as its invests £80 million in an expansion of its Global Headquarters in Craigavon, Northern Ireland.
The investment will see the construction of two new manufacturing, production and diagnostic laboratory facilities in Craigavon.
The construction of these two significant facilities will create over 550 jobs locally, spanning a range of lab and non-lab-based roles, with recruitment already commenced for some positions. This is part of the company's international recruitment drive which is expected to create 1,000 jobs in Northern Ireland over three years.
The expansion, which is part of the global investment programme announced in 2022, will significantly grow operations for two of the Group's business units, Almac Pharma Services and Almac Diagnostic Services.
Almac Pharma Services supports the development and commercialisation of new treatment options for a wide range of therapy areas including oncology and immunology. Almac Diagnostic Services offers a range of biomarker discovery, development and commercialisation solutions to Biopharma partners globally.
The first of these two major projects is a 100,000ft2 state-of-the-art multi-product Good Manufacturing Practice (GMP) facility for Almac Pharma Services. This Centre of Excellence for manufacturing will house a custom designed dispensary area, multiple production suites, process equipment wash facilities and a lineside warehouse for ambient, refrigerated and frozen storage. The new facility will primarily support solid oral dose products, complementing Almac's existing capabilities in this area.
The facility, which will be operational from Q3 2024, will expand Almac Pharma Services' existing manufacturing capabilities and offers additional capacity for further strategic production contracts. The high-specification production suites have been designed with flexibility and a wide range of uses in mind which offers opportunities for clients to install bespoke technology specific to their individual needs.
The second project is a 40,000 ft2 four-storey diagnostic development and manufacturing centre for Almac Diagnostic Services which will be completed by Q1 2024. The new facility will enable Almac Diagnostic Services to expand its assay development offering and to manufacture and distribute Companion Diagnostic (CDx) kits on a commercial scale to support growing client demand.
This expansion will enhance Almac's existing early phase biomarker development capabilities through to assay development and deployment in clinical trials, cementing the company's position in the market as a fully resourced partner of choice to pharma companies for manufacturing and commercialisation of companion diagnostics.
Alan Armstrong, Chief Executive of Almac Group said: "Almac is committed to re-investing all our profit back into the business.
"This £80 million expansion and the creation of 550 new, highly skilled jobs in Northern Ireland will ensure that we remain the global leaders in our industry, giving our clients and ultimately patients across the world who benefit from these therapeutics, the best possible offering from Almac."
These projects have been supported by Invest Northern Ireland who have welcomed the development and ongoing expansion of the Almac Group.
Jeremy Fitch, Executive Director of Business Growth Group, Invest Northern Ireland said: "Almac's commitment to innovation and excellence has positioned it as a cornerstone of our region's Life & Health Sciences success story and supported it to build a world-renowned reputation for ground-breaking work in the global pharmaceutical industry.
"We are delighted to support this investment which is creating hundreds of employment opportunities in the Armagh, Banbridge and Craigavon Borough Council area and will bolster Northern Ireland's reputation as a hub for pharma and diagnostic development. We commend Almac's dedication and vision and we look forward to witnessing the positive impact this investment will have on Northern Ireland's economy and the advancement of life changing medicines."
The investment will see the construction of two new manufacturing, production and diagnostic laboratory facilities in Craigavon.
The construction of these two significant facilities will create over 550 jobs locally, spanning a range of lab and non-lab-based roles, with recruitment already commenced for some positions. This is part of the company's international recruitment drive which is expected to create 1,000 jobs in Northern Ireland over three years.
The expansion, which is part of the global investment programme announced in 2022, will significantly grow operations for two of the Group's business units, Almac Pharma Services and Almac Diagnostic Services.
Almac Pharma Services supports the development and commercialisation of new treatment options for a wide range of therapy areas including oncology and immunology. Almac Diagnostic Services offers a range of biomarker discovery, development and commercialisation solutions to Biopharma partners globally.
The first of these two major projects is a 100,000ft2 state-of-the-art multi-product Good Manufacturing Practice (GMP) facility for Almac Pharma Services. This Centre of Excellence for manufacturing will house a custom designed dispensary area, multiple production suites, process equipment wash facilities and a lineside warehouse for ambient, refrigerated and frozen storage. The new facility will primarily support solid oral dose products, complementing Almac's existing capabilities in this area.
The facility, which will be operational from Q3 2024, will expand Almac Pharma Services' existing manufacturing capabilities and offers additional capacity for further strategic production contracts. The high-specification production suites have been designed with flexibility and a wide range of uses in mind which offers opportunities for clients to install bespoke technology specific to their individual needs.
The second project is a 40,000 ft2 four-storey diagnostic development and manufacturing centre for Almac Diagnostic Services which will be completed by Q1 2024. The new facility will enable Almac Diagnostic Services to expand its assay development offering and to manufacture and distribute Companion Diagnostic (CDx) kits on a commercial scale to support growing client demand.
This expansion will enhance Almac's existing early phase biomarker development capabilities through to assay development and deployment in clinical trials, cementing the company's position in the market as a fully resourced partner of choice to pharma companies for manufacturing and commercialisation of companion diagnostics.
Alan Armstrong, Chief Executive of Almac Group said: "Almac is committed to re-investing all our profit back into the business.
"This £80 million expansion and the creation of 550 new, highly skilled jobs in Northern Ireland will ensure that we remain the global leaders in our industry, giving our clients and ultimately patients across the world who benefit from these therapeutics, the best possible offering from Almac."
These projects have been supported by Invest Northern Ireland who have welcomed the development and ongoing expansion of the Almac Group.
Jeremy Fitch, Executive Director of Business Growth Group, Invest Northern Ireland said: "Almac's commitment to innovation and excellence has positioned it as a cornerstone of our region's Life & Health Sciences success story and supported it to build a world-renowned reputation for ground-breaking work in the global pharmaceutical industry.
"We are delighted to support this investment which is creating hundreds of employment opportunities in the Armagh, Banbridge and Craigavon Borough Council area and will bolster Northern Ireland's reputation as a hub for pharma and diagnostic development. We commend Almac's dedication and vision and we look forward to witnessing the positive impact this investment will have on Northern Ireland's economy and the advancement of life changing medicines."
Related Northern Ireland News Stories
Click here for the latest headlines.
25 November 2024
Other News In Brief
DfC Launch Public Consultation On Gender Pay Gap A consultation on proposed changes to Section 19 of the Employment Act (Northern Ireland) relating to the requirements for employers to publish information on the pay of male and female employees has been launched by the Department for Communities.
Other News In Brief
DfC Launch Public Consultation On Gender Pay Gap A consultation on proposed changes to Section 19 of the Employment Act (Northern Ireland) relating to the requirements for employers to publish information on the pay of male and female employees has been launched by the Department for Communities.
23 December 2022
DUP Welcome New Rapid Diagnostic Centres
The DUP has welcomed the announcement of three new Rapid Diagnostic Centres, which aim to improve NI's cancer treatment services. DUP Fermanagh and South Tyrone MLA Deborah Erskine, said: "Finding new ways of being able to diagnose and treat people should be at the forefront of transforming our health service.
DUP Welcome New Rapid Diagnostic Centres
The DUP has welcomed the announcement of three new Rapid Diagnostic Centres, which aim to improve NI's cancer treatment services. DUP Fermanagh and South Tyrone MLA Deborah Erskine, said: "Finding new ways of being able to diagnose and treat people should be at the forefront of transforming our health service.
09 November 2021
Almac To Create Over 1,000 New Jobs Across NI
Pharmaceutical development and manufacturing organisation, Almac Group, has announced the creation of more than 1,000 new jobs across Northern Ireland. The jobs are part of a three-year global recruitment drive to hire 1,800 new staff across 120 different roles.
Almac To Create Over 1,000 New Jobs Across NI
Pharmaceutical development and manufacturing organisation, Almac Group, has announced the creation of more than 1,000 new jobs across Northern Ireland. The jobs are part of a three-year global recruitment drive to hire 1,800 new staff across 120 different roles.
03 January 2007
Jobs boost for County Armagh
Around 60 new jobs are to be created in County Armagh due to an expansion at a pharmaceutical company. Almac Pharma Services is investing £5.4 million into its headquarters in Craigavon in a bid to strengthen its development in pharmaceutical products.
Jobs boost for County Armagh
Around 60 new jobs are to be created in County Armagh due to an expansion at a pharmaceutical company. Almac Pharma Services is investing £5.4 million into its headquarters in Craigavon in a bid to strengthen its development in pharmaceutical products.
03 May 2024
Health Minister Welcomes New GP-Led Lung Health Service
Health Minister Robin Swann has welcomed the launch of a new GP-led service to improve lung health in the Armagh/Dungannon area. The innovative Early Respiratory Diagnostic Hub, based at Moy Health Centre, will serve thousands of patients from 23 General Practice surgeries through the provision of accessible and advanced lung function testing.
Health Minister Welcomes New GP-Led Lung Health Service
Health Minister Robin Swann has welcomed the launch of a new GP-led service to improve lung health in the Armagh/Dungannon area. The innovative Early Respiratory Diagnostic Hub, based at Moy Health Centre, will serve thousands of patients from 23 General Practice surgeries through the provision of accessible and advanced lung function testing.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
